Volume 24, Issue 3 (11-2018)                   Back to this Issue | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mokhtari A M, Riahi S, Fathalipour M, Delam H, Hashemnejad M, Hassanipour S. The age-standardized rate of female genital cancers in Iran: A systematic review and meta-analysis. Hayat. 2018; 24 (3) :204-219
URL: http://hayat.tums.ac.ir/article-1-2495-en.html
1- Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2- Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
3- Dept. of Pharmacology, School of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
4- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
5- Dept. of Obstetrics and Gynecology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
6- Gastrointestinal & Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, Rasht, Iran , soheil.epid@gmail.com
Abstract:   (771 Views)
Background & Aim: Female genital cancers are the third most common type of malignancy among women. Considering the importance of these cancers, the present study was conducted to determine the age-standardized rate (ASR) of female genital cancers in Iran.
Methods & Materials: In this systematic review, six international databases (Medline/PubMed, ProQuest, Scopus, Embase, ScienceDirect, and Google Scholar), and four national databases (Scientific Information Database, MagIran, IranMedex, and IranDoc) were searched in 2017. Thereafter, Persian and English papers referring to the ASR of female genital cancers in Iran were included. The Joanna Briggs checklist was used to evaluate the quality of studies. Data were independently extracted by two reviewers.
Results: A total of 264 papers were found in the initial search of the databases, and 27 papers were included for final analysis. Based on the random-effect model, the ASR was 2.07 (95% CI, 1.83-2.31) for cervical cancer, 3.15 (95% CI, 2.75-3.54) for ovarian cancer, and 1.52 (95% CI, 1.32-1.73) per 100,000 for uterine cancer.
Conclusion: The ASR of female genital cancers in Iran was lower than other countries of the world. It should be noted that the results of this review must be judged with caution because of the high heterogeneity of the studies.
Full-Text [PDF 1099 kb]   (398 Downloads)    
Type of Study: Research | Subject: Nursing Care
Published: 2018/11/12 | ePublished: 2018/11/12

Add your comments about this article : Your username or Email:

Send email to the article author

© 2019 All Rights Reserved | Journal of hayat

Designed & Developed by : Yektaweb